Handelsavisen
prelaunch
Companies Healthcare 039840.KQ
03
039840.KQ KOSDAQ Medical Equipment, Supplies & Distribution

Dio Corp

$16 230,00
Open in Charts → Attach watcher ⌖
KRW
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
217,3B KRW
P/E
EV / Rev
Div yield
Op margin
6,0 %
ROE
-0,7 %
Net margin
-0,8 %
Debt / equity
0,42
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

Dio Corp is a South Korean company that provides medical equipment, supplies, and distribution services, primarily serving the healthcare sector.

Business. Dio Corp (039840.KQ) is a healthcare services and equipment company operating within the medical equipment, supplies, and distribution industry. The firm primarily engages in the sale of medical products, though specific details regarding its operating segments and geographic presence are not disclosed. Dio Corp is listed on the KOSDAQ exchange.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
ActivityHealthcare Services & Equipment
Generated · model-assisted
Sell-side consensus
BUY2 analysts
2 buy0 hold0 sell
Avg 12m price target23 500,00

Analyst recommendations

2 analysts · consensus Buy
Buy2
Hold0
Sell0
12-month price target
23 500,00
Consensus of sell-side coverage.
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
Buy
2 analysts · indicative
Ownership
not yet wired
Profitability
-0,7 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning 039840.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to 039840.KQ. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Dio Corp (039840.KQ) is a healthcare services and equipment company operating within the medical equipment, supplies, and distribution industry. The firm primarily engages in the sale of medical products, though specific details regarding its operating segments and geographic presence are not disclosed. Dio Corp is listed on the KOSDAQ exchange.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryMedical Equipment, Supplies & Distribution
    ActivityHealthcare Services & Equipment
    AI synthesis
    GENERATED

    Dio Corp's capital structure is characterized by a debt-to-equity ratio of 0.42, indicating a relatively conservative leverage position compared to industry norms. The company holds 39.6 billion KRW in cash and equivalents, but its long-term debt of 80.9 billion KRW results in a net cash position of -41.3 billion KRW, raising liquidity concerns. The current ratio of 1.43 suggests the company can cover its short-term liabilities with its current assets, but the negative net cash position highlights a potential liquidity risk.

    Profitability metrics for Dio Corp show a return on equity (ROE) of -0.71% and a return on assets (ROA) of -0.42%, both of which are negative and significantly below the industry median for medical equipment and supplies firms. The company reported a net loss of 1.36 billion KRW for the period, despite generating 164.08 billion KRW in revenue and 110.23 billion KRW in gross profit. These figures suggest operational inefficiencies or cost overruns that are eroding profitability.

    Dio Corp's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no geographic diversification provided in the available data. This lack of segmental or geographic breakdown limits the ability to assess exposure to regional or product-specific risks.

    The company's growth trajectory appears to be under pressure, with no specific revenue growth rates provided in the input data. However, the negative net income and declining ROE suggest a challenging operating environment. Analysts have set a mean price target of 23,500 KRW, implying a potential upside of 46.9% from the current market price of 16,000 KRW. This optimism is tempered by the company's current financial performance and the absence of clear growth drivers.

    Risk factors for Dio Corp include its negative net cash position, which could limit its ability to fund operations or invest in growth without external financing. The risk assessment indicates a medium liquidity risk and a low dilution risk, but the negative net cash position is a key flag. The company's free cash flow of 1.38 billion KRW is modest and may not be sufficient to support significant capital expenditures or debt reduction without additional financing.

    Recent events, including analyst price targets and recommendations, suggest a cautiously optimistic outlook from the investment community. The mean recommendation of 1.50 (on a scale from 1 to 5) indicates a slight bias toward buying, with one strong-buy and one buy recommendation. However, the absence of recent filings or transcripts limits the ability to assess the company's strategic direction or operational updates.

    Key takeaways
    • Dio Corp operates in the medical equipment and supplies industry with a conservative debt structure but a negative net cash position.
    • The company's profitability is weak, with negative ROE and ROA, and a net loss despite strong gross profit.
    • Revenue concentration in a single segment and lack of geographic diversification increase operational risk.
    • Analysts are cautiously optimistic, with a mean price target of 23,500 KRW, but the company's financial performance remains a concern.
    • Liquidity risk is moderate, but the negative net cash position could limit growth or operational flexibility.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $16 230,00
    Market cap
    $214.22B
    Enterprise value
    $255.53B
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    15.4x
    P / B
    1.1x
    P / Tangible book
    1.1x
    Tangible book
    $191.68B
    Net cash
    -$41.31B
    Current ratio
    1.4
    Debt / equity
    0.4
    ROA
    -0.4%
    ROE
    -0.7%
    Cash conversion
    -1217.0%
    CapEx / revenue
    -3.0%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Next quarternear-term
    Earnings · next quarterconf 45 %
    EPS
    Consensus EPS
    1 533,60
    Predicted surprise
    +0,00
    Beat probability
    45 %
    Analysts
    2
    Other metrics
    Revenue
    no estimate
    Segment revenue
    no estimate
    Margin
    no estimate
    Segment margin
    no estimate
    as of 2026-05-14 · Earnings Surprise V1
    Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.
    Full fiscal year~1 year ahead
    Full fiscal year · our forecast vs guidance vs consensus
    MetricOur forecastGuidanceConsensus
    EPSno estimateno estimate1 533,60
    Revenueno estimateno estimate200,2B KRW
    Operating incomeno estimateno estimate27,2B KRW
    Full-year consensus mean (period as reported by source) · consensus in KRW. Company-level full-year forecast and management guidance are not yet modelled at scale — shown as "no estimate", never inferred.
    Probabilistic model output — not investment advice. · generated 2026-08-04

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Consensus distribution

    sell-side coverage
    Recommendation distribution2 analysts
    Strong buy1
    Buy1
    Hold0
    Sell0
    Strong sell0
    12-month price target$23 500,00 · Median $23 500,00
    Low $22 000,00High $25 000,00
    Operating income · consensus27,2B KRW
    EPS surprise
    −106,5 %
    reported vs consensus · miss
    Revenue surprise
    −18,1 %
    reported vs consensus · miss

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    Low$22 000,00
    Mean$23 500,00
    Median$23 500,00
    High$25 000,00
    Spot$16 230,00
    +44.8 %implied to mean12-month sell-side price targets · ▲ spot

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin6,0 %Above median
    Net Margin-0,8 %Below median
    ROE-0,7 %Below median
    Capex / Rev-3,0 %Above median
    D/E0,42Below median
    Cash Conv-12,17Bottom quartile

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Ev To Operating Cash Flow
      enterprise_value / operating_cash_flow
    • Return On Equity
      net_income / total_equity
    • Price To Book
      market_price / (adjusted_book_value / shares_outstanding_diluted)
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Market Price
      input from market-data provider (delayed close or quote-shim mid)
    • Market Cap
      market_price * shares_outstanding_diluted
    Source documents
    • Dio Corp Market data — financials · 2026-05-26
    • Dio Corp Market data — analyst estimates · 2026-05-26

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    039840.KQCanonical
    KOSDAQ · KRW

    Intel & risk

    PredictorBeat prob45 %Surprise+0,00Full forecast →
    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (90d)
    2026-06-20 12:34 UTCANALYSTAnalyst coverage initiated
    2026-06-20 12:34 UTCANALYSTAnalyst coverage initiated
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage